Abstract
Background and importanceDalbavancin is a semisynthetic glycopeptide active against Gram-positive bacteria, approved in acute bacterial skin and skin structure infections(ABSSSI). Its use has been extended, in selected patients, to other...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have